medica glp-1 coverage CMS Issues Guidance on Anti-Obesity Drugs Have you heard? There's a

Almost every time I pushed through, I regretted it

20, the 41-year-old country music star explained that changing his addictive relationship with food was key to jumpstarting his fitness journey

The Zytiga case shows how quickly market share can evaporate once generics arrive

That is not what a man on TRT is doing, and any honest version of this story has to say so out loud

But if the device proves safe and comes with fewer side effects than existing options, some see an opportunity for it to address one of the biggest challenges in obesity treatment: helping patients stay on therapy and maintain their weight loss over time